Method and device for sampling and analyzing interstitial fluid and whole blood samples

a sampling method and interstitial fluid technology, applied in the field of sampling and analyzing interstitial fluid and whole blood samples, can solve the problems of scar tissue build-up, difficult to obtain a sample in the region, and reduce patient compliance in regular monitoring

Inactive Publication Date: 2007-01-25
LIFESCAN IP HLDG LLC
View PDF76 Cites 346 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0006] It is desirable to be able to measure the concentration of analytes in humans or other animals without having to draw a blood sample by conventional methods. It is further desirable to be able to do so with an inexpensive disposable device that is simple enough for home or hospital bedside use.

Problems solved by technology

Invasive techniques used to obtain a blood sample for analysis have the disadvantage of being painful, which can reduce patient compliance in regular monitoring.
Repeated testing, e.g., on a fingertip, can result in scar tissue build-up which makes obtaining a sample in that region more difficult.
Moreover, invasive sampling procedures pose a risk of infection or disease transmission.
However, there is no method disclosed for analyzing the drawn samples that is suitable for home use or hospital bedside use.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method and device for sampling and analyzing interstitial fluid and whole blood samples
  • Method and device for sampling and analyzing interstitial fluid and whole blood samples
  • Method and device for sampling and analyzing interstitial fluid and whole blood samples

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

Introduction

[0038] The following description and examples illustrate various embodiments of the present invention in detail. Those of skill in the art will recognize that there are numerous variations and modifications of this invention that are encompassed by its scope. Accordingly, the description of a preferred embodiment should not be deemed to limit the scope of the present invention. Methods and devices for optimizing sampling of fluid samples are discussed further in copending U.S. patent application Ser. No. 09 / 536,234, filed on Mar. 27, 2000, entitled “METHOD OF PREVENTING SHORT SAMPLING OF A CAPILLARY OR WICKING FILL DEVICE,” which is incorporated herein by reference in its entirety.

[0039] The invention disclosed in this application is a method and device for combining the sampling and analyzing of a fluid sample from sub-dermal tissue in a device suitable for hospital bedside and home use. The fluid sample can comprise, but is not limited to, interstitial fluid or whol...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention disclosed in this application is a method and device for combining the sampling and analyzing of sub-dermal fluid samples, e.g., interstitial fluid or whole blood, in a device suitable for hospital bedside and home use. It is applicable to any analyte that exists in a usefully representative concentration in the fluid, and is especially suited to the monitoring of glucose.

Description

RELATED APPLICATIONS [0001] This application is a continuation of U.S. application Ser. No. 10 / 369,120, filed Feb. 13, 2003, which is a continuation of U.S. application Ser. No. 10 / 166,487, filed Jun. 10, 2002, now U.S. Pat. No. 6,939,312, which is a continuation of application Ser. No. 09 / 536,235, filed Mar. 27, 2000, now U.S. Pat. No. 6,612,111.FIELD OF THE INVENTION [0002] The present invention relates to a method and device for combining the sampling and analyzing of interstitial fluid or whole blood samples which is suitable for hospital bedside and home use. BACKGROUND OF THE INVENTION [0003] The management of many medical conditions requires the measurement and monitoring of a variety of analytes in bodily fluid. Historically, the measurement of analytes in blood has required an invasive technique, such as a venipuncture or finger puncture, to obtain blood for sampling purposes. An example of an analyte which is routinely tested by obtaining a blood sample through an invasive...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): G01N27/26A61B5/00G01N33/48A61B5/15A61B10/00G01N33/49
CPCA61B5/1411A61B5/14514A61B5/14532A61B2562/0295A61B5/14865A61B2010/008A61B5/14546A61B5/150022A61B5/150213A61B5/150221A61B5/150358A61B5/150389A61B5/150503A61B5/150755A61B5/15105A61B5/15113A61B5/15117A61B5/15142A61B5/1519A61B5/1405
Inventor HODGES, ALASTAIRCHATELIER, RONALDCHAMBERS, GARRY
Owner LIFESCAN IP HLDG LLC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap